IBRX → $100.00 by Mar 24, 2029.

This had a mini squeeze back in January and February. I think it could repeat. Probably won't see it rise to the $50s like some were hoping earlier this year, at least not any time soon (though I am personally a long-term holder and believe in a few years it will be over $100), but an increase of 50-150% is reasonable. Let's look at the set up: The stock focuses on drugs to treat cancer. Right now they have approval …